Clinical trials
Pneumonia trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 5 |
| 2020 | 14 |
| 2021 | 5 |
| 2022 | 4 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 8 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bursa Yuksek Ihtisas Training and Research Hospital | 3 |
| Pfizer | 3 |
| Ataturk University | 2 |
| Bakirkoy Dr. Sadi Konuk Research and Training Hospital | 2 |
| Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 2 |
| Gaziosmanpasa Research and Education Hospital | 2 |
| TC Erciyes University | 2 |
| Ankara City Hospital Bilkent | 1 |
| Aridis Pharmaceuticals, Inc. | 1 |
| Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumonia | 45 |
| COVID-19 | 19 |
| Coronavirus Infections | 8 |
| Infections | 4 |
| Pneumonia, Viral | 4 |
| Respiratory Tract Infections | 4 |
| Lung Diseases | 3 |
| Pulmonary Atelectasis | 3 |
| Respiratory Insufficiency | 3 |
| Acute Lung Injury | 2 |
Trials
Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.